Medical Cannabis: Benefit Often Not Proven
outside of those assessed in clinical studies – for example, due to chronic pain syndrome (27 percent), sustained back pain (7 percent), spasticity (6 percent), or polyneuropathy (5 percent). Four Years [...] manner and are available on the market, and especially well assessed, effective, and repeatedly tested pain medicine.” Doubt Regarding Therapeutic Use It is notable to the study authors that over 50 percent